Amplification and overexpression of mdm2 gene in ependymomas

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Ependymomas rarely show p53 gene alteration, and the tumorigenic mechanism of ependymomas still remains to be elucidated. We investigated the amplification and overexpression of mdm2 gene, whose product (MDM2) is considered to be one of the major cellular regulators of p53-mediated growth control, in 26 specimens of ependymomas obtained from 20 patients. The majority of the ependymomatous samples (96%) showed at least focal immunopositivity for MDM2; however, only 8% of the samples were immunopositive for p53. mdm2 gene amplification was detected in 35% of the samples by differential polymerase chain reaction, all of which overexpressed MDM2. These results suggest that the amplification and/or overexpression of mdm2 may be one of the major molecular events occurring in the tumorigenesis of ependymomas.

Original languageEnglish
Pages (from-to)548-553
Number of pages6
JournalModern Pathology
Volume13
Issue number5
DOIs
Publication statusPublished - Jan 1 2000

Fingerprint

Ependymoma
Genes
Gene Amplification
p53 Genes
Carcinogenesis
Polymerase Chain Reaction
Growth

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Amplification and overexpression of mdm2 gene in ependymomas. / Suzuki, Satoshi; Iwaki, Toru.

In: Modern Pathology, Vol. 13, No. 5, 01.01.2000, p. 548-553.

Research output: Contribution to journalArticle

@article{848a9fed500c4363964b9bd7989f1cdb,
title = "Amplification and overexpression of mdm2 gene in ependymomas",
abstract = "Ependymomas rarely show p53 gene alteration, and the tumorigenic mechanism of ependymomas still remains to be elucidated. We investigated the amplification and overexpression of mdm2 gene, whose product (MDM2) is considered to be one of the major cellular regulators of p53-mediated growth control, in 26 specimens of ependymomas obtained from 20 patients. The majority of the ependymomatous samples (96{\%}) showed at least focal immunopositivity for MDM2; however, only 8{\%} of the samples were immunopositive for p53. mdm2 gene amplification was detected in 35{\%} of the samples by differential polymerase chain reaction, all of which overexpressed MDM2. These results suggest that the amplification and/or overexpression of mdm2 may be one of the major molecular events occurring in the tumorigenesis of ependymomas.",
author = "Satoshi Suzuki and Toru Iwaki",
year = "2000",
month = "1",
day = "1",
doi = "10.1038/modpathol.3880095",
language = "English",
volume = "13",
pages = "548--553",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Amplification and overexpression of mdm2 gene in ependymomas

AU - Suzuki, Satoshi

AU - Iwaki, Toru

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Ependymomas rarely show p53 gene alteration, and the tumorigenic mechanism of ependymomas still remains to be elucidated. We investigated the amplification and overexpression of mdm2 gene, whose product (MDM2) is considered to be one of the major cellular regulators of p53-mediated growth control, in 26 specimens of ependymomas obtained from 20 patients. The majority of the ependymomatous samples (96%) showed at least focal immunopositivity for MDM2; however, only 8% of the samples were immunopositive for p53. mdm2 gene amplification was detected in 35% of the samples by differential polymerase chain reaction, all of which overexpressed MDM2. These results suggest that the amplification and/or overexpression of mdm2 may be one of the major molecular events occurring in the tumorigenesis of ependymomas.

AB - Ependymomas rarely show p53 gene alteration, and the tumorigenic mechanism of ependymomas still remains to be elucidated. We investigated the amplification and overexpression of mdm2 gene, whose product (MDM2) is considered to be one of the major cellular regulators of p53-mediated growth control, in 26 specimens of ependymomas obtained from 20 patients. The majority of the ependymomatous samples (96%) showed at least focal immunopositivity for MDM2; however, only 8% of the samples were immunopositive for p53. mdm2 gene amplification was detected in 35% of the samples by differential polymerase chain reaction, all of which overexpressed MDM2. These results suggest that the amplification and/or overexpression of mdm2 may be one of the major molecular events occurring in the tumorigenesis of ependymomas.

UR - http://www.scopus.com/inward/record.url?scp=0034042177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034042177&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3880095

DO - 10.1038/modpathol.3880095

M3 - Article

C2 - 10824927

AN - SCOPUS:0034042177

VL - 13

SP - 548

EP - 553

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -